美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Baillie Gifford International Alpha ETF

25.00

-0.1843-0.73%

盤後：25.040.0381+0.15%16:10 EDT

成交量：332

成交額：8,318

市值：3.25億

市盈率：- -

高：25.04

開：25.04

低：25.00

收：25.19

52周最高：25.97

52周最低：23.97

股本：1,301.20萬

流通股本：1,301.20萬

量比：0.04

換手率：0.00%

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

諾和諾德與Anthropic將合作推進藥物研發，諾和諾德將使用Claude輔助研發工作流程。

諾和諾德(NVO.US)盤前拉升升逾1%，公司將與Anthropic合作推進藥物研發。

諾和諾德將使用Claude Science開展研發工作流。

諾和諾德與Anthropic開展合作，藉助Claude推進藥物研發。

市場消息：諾和諾德(NVO.US)與Anthropic將合作推進藥物研發。

諾和諾德(NVO.US)首席執行官：諾和諾德需要擴大其業務範圍以應對未來挑戰。

美國口服減肥藥競爭升級！禮來(LLY.US)Foundayo搶下三成新患者，諾和諾德(NVO.US)先發優勢收窄

美國口服減肥藥競爭升級！禮來(LLY.US)Foundayo搶下三成新患者，諾和諾德(NVO.US)先發優勢收窄

台積電德國廠封頂，廠房主體工程完成

時序進入第三季下旬，台積電3nm、2nm先進製程與CoWoS先進封裝產能持續供不應求。供應鏈人士透露，英偉達、蘋果等持續

美股開盤 | 三大股指集體低開！半導體板塊普跌，邁威爾科技、ARM跌超7%

老虎资讯综合

諾和諾德公司開啓股份回購計劃。

諾和諾德(NVO.US)更名「Novo」煥新出發多線突圍能否驅散股價陰霾？

諾和諾德(NVO.US)更名「Novo」煥新出發多線突圍能否驅散股價陰霾？

諾和諾德更名為「諾和（Novo）」，全力爭奪減肥藥市場份額

环球市场播报

諾和諾德(NVO.US)：公司將品牌名稱更新為「Novo」，並調整企業文化。此舉是為了幫助公司重新奪回減肥藥市場份額。

歐洲科技股普遍走低阿斯麥下跌4.1%

东方财富Choice...

阿斯麥歐股跌超4%

諾和諾德：「諾和」將作為公司通用名稱；諾和諾德A/S仍為法定名稱。

諾和諾德計劃更名將去掉「諾德」字樣

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/BGIA/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BGIA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BGIA\",,,,,undefined,":{"symbol":"BGIA","market":"US","secType":"STK","nameCN":"Baillie Gifford International Alpha ETF","latestPrice":25.0009,"timestamp":1789761600000,"preClose":25.1852,"halted":0,"volume":332,"hourTrading":{"tag":"盘后","latestPrice":25.039,"preClose":25.0009,"latestTime":"16:10 EDT","volume":8,"amount":200.0072,"timestamp":1789762203686,"change":0.0381,"changeRate":0.001524,"amplitude":0},"delay":0,"changeRate":-0.007317789813064689,"floatShares":13012033,"shares":13012033,"eps":0,"marketStatus":"已收盤","change":-0.1843,"latestTime":"09-18 16:00:00 EDT","open":25.039,"high":25.039,"low":25.0009,"amount":8318,"amplitude":0.001513,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":25.1852,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":25.039,"preClose":25.0009,"latestTime":"16:10 EDT","volume":8,"amount":200.0072,"timestamp":1789762203686,"change":0.0381,"changeRate":0.001524,"amplitude":0},"volumeRatio":0.037739},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BGIA\",,,,,undefined,":{"symbol":"BGIA","floatShares":13012033,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.037739,"shares":13012033,"dividePrice":0,"high":25.039,"amplitude":0.001513,"preClose":25.1852,"low":25.0009,"week52Low":23.9707,"pbRate":"--","week52High":25.97,"institutionHeld":0,"latestPrice":25.0009,"eps":0,"divideRate":0,"volume":332,"delay":0,"ttmEps":0,"open":25.039,"prevYearClose":25.2,"prevWeekClose":25.3728,"prevMonthClose":25.6781,"prevQuarterClose":24.4419,"fiveDayClose":25.3728,"twentyDayClose":25.5318,"sixtyDayClose":24.4745},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BGIA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BGIA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BGIA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BGIA\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667988768","title":"諾和諾德與Anthropic將合作推進藥物研發，諾和諾德將使用Claude輔助研發工作流程。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667988768","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667988768?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 20:08","pubTimestamp":1789560535,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BGIA","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667988257","title":"諾和諾德(NVO.US)盤前拉升升逾1%，公司將與Anthropic合作推進藥物研發。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667988257","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667988257?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 20:01","pubTimestamp":1789560102,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BGIA","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667102988","title":"諾和諾德將使用Claude Science開展研發工作流。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667102988","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667102988?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 20:00","pubTimestamp":1789560053,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667988109","title":"諾和諾德與Anthropic開展合作，藉助Claude推進藥物研發。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667988109","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667988109?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 20:00","pubTimestamp":1789560027,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BGIA","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667988100","title":"市場消息：諾和諾德(NVO.US)與Anthropic將合作推進藥物研發。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667988100","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667988100?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 20:00","pubTimestamp":1789560026,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BGIA","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667406476","title":"諾和諾德(NVO.US)首席執行官：諾和諾德需要擴大其業務範圍以應對未來挑戰。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667406476","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667406476?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 21:23","pubTimestamp":1789478634,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667618217","title":"美國口服減肥藥競爭升級！禮來(LLY.US)Foundayo搶下三成新患者，諾和諾德(NVO.US)先發優勢收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=2667618217","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667618217?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 11:02","pubTimestamp":1789441373,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，礼来周一表示，其口服减肥药Foundayo已在美国口服肥胖症治疗市场的新增患者中占据超过30%的份额，缩小了丹麦竞争对手诺和诺德凭借其Wegovy口服片剂所取得的早期领先优势。据了解，礼来的口服减肥药Foundayo于4月初上市，比诺和诺德的竞品Wegovy口服片晚了约三个月。诺和诺德在1月表示，预计到2030年，口服药物将占GLP-1减肥治疗使用量的三分之一以上。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496046.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BGIA","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667249618","title":"美國口服減肥藥競爭升級！禮來(LLY.US)Foundayo搶下三成新患者，諾和諾德(NVO.US)先發優勢收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=2667249618","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667249618?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 11:02","pubTimestamp":1789441373,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BGIA","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667966697","title":"台積電德國廠封頂，廠房主體工程完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2667966697","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667966697?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 09:31","pubTimestamp":1789435901,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["KNOW","CWI","WUGI","CHPX","ASIA","TSMX","TWN","TINS","AVSE","CGNG","AVEM","UMMA","EMXC","AVXC","EMM","ESIM","IEMG","TSM","BLOX","TWSC","LU2250418816.HKD","CGDG","LU0384037296.USD","TTEQ","EMC","03145","CORO","BGIA","TSMY","EWT","TEK","LU2237443622.USD","TSMU","EDZ","AIQ","SPTE","MEMX","SPWO","CGIC","TSMZ","CNEQ","SMH","FLTW","TSMG","STSM","CGGO","FDTX","LU2237443978.SGD","ADVE","BAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667697348","title":"時序進入第三季下旬，台積電3nm、2nm先進製程與CoWoS先進封裝產能持續供不應求。供應鏈人士透露，英偉達、蘋果等持續","url":"https://stock-news.laohu8.com/highlight/detail?id=2667697348","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667697348?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 09:21","pubTimestamp":1789435287,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HBMX","LRCC","THMR","TSM","UMCX","TSMU","TWSC","DRMP","SEMY","NVDS","TSMX","AAPL","ASIA","ABFL","EDZ","EWT","AMAU","NVDA","TCAI","ASMG","AMDC","TSMZ","FLTW","VGT","CHPX","SEMI","AMKL","ASMZ","AMKX","TMYY","EUVX","CWI","BGIA","NVDL","SHOC","AMDG","EMXC","NVDB","AMUU","TSEU","XSEM","IEMG","2NVD.UK","TWN","AMDL","TSMY","TSMG","KSTR","INTW","BESIY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131866623","title":"美股開盤 | 三大股指集體低開！半導體板塊普跌，邁威爾科技、ARM跌超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1131866623","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131866623?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 21:30","pubTimestamp":1789392630,"startTime":"0","endTime":"0","summary":"9月14日，美股三大股指集体低开，道琼斯指数跌0.24%，标普500指数跌0.71%，纳斯达克综合指数跌1.20%。半导体板块普跌，迈威尔科技、ARM跌超7%，英特尔、阿斯麦跌超6%，积电、博通跌超3%；The Elmet Group涨超32%，获战争部4.5亿美元投资承诺+20亿美元国防大单。","market":"us","thumbnail":"https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1235294995.USD","LU0784384876.USD","LU2954938101.SGD","LU0203202063.USD","LU0742534661.SGD","LU1868836914.USD","SPYQ","LU0912757837.SGD","FDTX","ASMZ","AVSE","LU2322448957.HKD","EMM","EMXC","LU1303367103.USD","LU1778281490.HKD","09086","BK4612","AIQ","WUGI","LU0215105999.USD","LU0308772762.SGD","SG9999015952.SGD","IE00BFSS7M15.SGD","LU2298321311.HKD","SOXW","LU2279689827.SGD","LU2244417387.USD","LU0719512351.SGD","LU2125154935.USD","LU2458330243.SGD","LU0061475181.USD","LU2211814178.USD","LU2237443382.USD","CNEQ","CNAV","SMHX","LU1244550577.SGD","LU0820561818.USD","TSMX","LU0541501648.USD","OCTP","07522","BK4512","LU1232071149.USD","IE00BVYPNV92.GBP","LU0251132253.USD","TTXD","ARLU","LU1066051811.HKD","NJAN","LU0965509010.AUD","LU1282649810.SGD","QQQA","LU0683600562.USD","IE000MB6IJN5.SGD","LU2355687059.USD","LU2663582299.SGD","UXAP","IE00BGHQDM52.EUR","LU0094547139.USD","DJUN","LU0708994859.HKD","LU0345774631.USD","LU0081259029.USD","LU0784385170.HKD","BGIA","MAYM","IE00BFSS8Q28.SGD","LU0053666078.USD","LU0321505868.SGD","LU0274383776.USD","IE00BYV24P56.USD","LU0784383803.USD","IE00BN8TJ469.HKD","LU0029864427.USD","LU0359202008.SGD","LU1868837565.USD","LU2456880835.USD","LU1551013342.USD","UPRO","LU1989764748.USD","LU2089283258.USD","LU2347655073.USD","GAUG","SPXU","LU0082616367.USD","IE00BKDWB100.SGD","QQQX","AIS","EPAI","IE00BJTD4V19.USD","LU1066051225.USD","LU2106854487.HKD","IE00BK4W5L77.USD","LU2272731865.HKD","LU2023250504.SGD","LU1508157978.USD","LU0149725797.USD","LU1261432733.SGD","IE0004091025.USD","LU0788109477.HKD","LU1720051108.HKD","AVXC","LU0943347566.SGD","LU1037948897.HKD","LU0354030438.USD","LU0289961442.SGD","IE00BGHQF631.EUR","IE00B775H168.HKD","07266","IEMG","LU0061474960.USD","BK4581","RSDE","LU0345768740.USD","QID","LU0203201768.USD","JGRO","IE00B3S45H60.SGD","LU0238689110.USD","LU1815333072.USD","LU2265009873.SGD","AVS","LU0965508806.USD","LU2211815571.USD","JULP","SQQQ","PSQ","HIBL","CGBL","LU1734074674.USD","PBMY","LU0097036916.USD","IE00BMPRXR70.SGD","IE00B1XK9C88.USD","FFGX","QMAR","BK4526","LU2237443549.SGD","IE00B19Z9Z06.USD","AVL","LU0006306889.USD","PMSE","LU0251131958.USD","SG9999001440.SGD","LU1914381329.SGD","LU0276348264.USD","BK4515","CGNG","JUNT","IE000WAW04H5.SGD","IE0034235303.USD","LU1400636657.SGD","LU2491050071.SGD","LU1316542783.SGD","IE00BJJMRY28.SGD","LU0175139822.USD","LU0203345920.USD","LU1003077747.HKD","DJUL","LU0708995401.HKD","LU2999663052.SGD","FEBT","LU0048573561.USD","LU1069344957.HKD","USD","LINT","LU1804176565.USD","FLJJ","SG9999003800.SGD","LU1169589451.USD","SPTE","LU0109392836.USD","LU1691799644.USD","TTXU","SCHD","SG9999004303.SGD","IE00BLSP4239.USD","07261","BK4529","LU0256863811.USD","BK4598","PMNV","LU1066053197.SGD","TSMU","VOO","LU2491050154.USD","TEK","LU0316494557.USD","LU1267930730.SGD","LU1935043452.HKD","LU0949170426.SGD","LU1674673428.USD","LU2272731600.USD","LU2473716301.USD","LU1935042488.USD","LU0345769128.USD","CHPX","NOCT","LU0359201885.HKD","SMH","LU2931357623.SGD","LU0979878070.USD","LU1642822529.SGD","LU2054465674.USD","LU1035775433.USD","LU2089284900.SGD","BK4533","ASML","LU1023057109.AUD","DDM","IE00BQXX3F31.USD","LU0323240290.USD","LU1153585028.USD","LU2023251221.USD","LU0345774391.USD","AIPI","LU1670628061.USD","SG9999011175.SGD","LU2236285917.USD","HK0000914660.USD","LU2087625088.SGD","SEPP","BK4551","TWOX","LU1366192091.USD","LU2237957811.SGD","ARMU","LU0640476718.USD","LU1923623000.USD","LU2125154778.USD","MYMmain","SGXZ23171101.USD","MEMX","HK0000304797.USD","JANP","LU2360032135.SGD","DFUS","LU1548497426.USD","DBEF","LU0868494617.USD","LU0320765646.SGD","BK4591","LU1674673691.USD","LU2168564222.USD","PQNT","LU0859254822.USD","SGXZ81514606.USD","LU0211328371.USD","LU0345768153.USD","LU1868837136.USD","BK4609","QLD","LU2125909593.SGD","LU2471134879.HKD","LU2764262908.HKD","LU2092937221.SGD","LU1267930573.SGD","LU2322448791.USD","LU1629891620.HKD","LU2462591350.SGD","LU0211327993.USD","LU1267930490.SGD","LU2065169927.USD","BAI","LU0289960550.SGD","SCHK","SDS","LU0965509283.SGD","OEX","LU0942090050.USD","QQQM","LU0056508442.USD","LU2347655156.SGD","LU2430703251.USD","DBEU","TSM","SSO","LU0353189763.USD","MRVL","APOC","IE00BFXG0V08.USD","STSM","FENI","LU1861215975.USD","LU0787776722.HKD","LU2210150020.SGD","LU2487616109.SGD","LU2272731782.SGD","LU0820561909.HKD","LU0820562030.AUD","HBMX","FAI","IE00B894F039.SGD","LU2168564065.EUR","SPUU","SPYM","GPIQ","IE0005OL40V9.USD","DTCR","LU0738911758.USD","LU2462157665.USD","IE00BMPRXN33.USD","CGDG","LU0256863902.USD","03455","CJUL","DIA","LU0488056044.USD","LU1718418525.SGD","LU1720051017.SGD","AVGO","QQQ","LU1242518857.USD","BK4548","LU0949170772.SGD","SGXZ51526630.SGD","BK4585","LU1162221912.USD","LU2746668974.SGD","LU0476273544.USD","IE00B4JS1V06.HKD","LU0057025933.USD","LU1066051498.USD","LU1145028129.USD","LU2294711713.HKD","LU2065170008.USD","HK0000532082.HKD","IE00BZ1G4Q59.USD","IETC","LU1623119135.USD","LU2210149790.SGD","LU2543165471.USD","OCTT","UMMA","IE00B5949003.HKD","09834","SG9999000418.SGD","SMAX","BK4505","DAUG","MAYP","LU2023250330.USD","IE00B3PB1722.GBP","RSST","SPRX","LU1861220033.SGD","LU0128525929.USD","PQV","LU0354030511.USD","IE0004086264.USD","LU2896262040.SGD","IE00BQXX3C00.GBP","LU1301847155.USD","BK4605","LU0143863198.USD","LU0345770308.USD","LU0345770993.USD","LU1645745479.HKD","LU0187121727.USD","LU2602419157.SGD","LU1670711040.USD","TWN","IE00BVYPNW00.USD","AVEM","LU2462591277.SGD","LU0198837287.USD","LU2505996509.AUD","MRVX","LU0823421416.USD",".SPX","LU2083900584.USD","LU0133085943.USD","AVGC","HAKY","IEFA","IVV","FXL","LU1400636574.HKD","LU0466842654.USD","LU2764263203.CNY","SDOW","ASMH","LU0264606111.USD","SPXS","LU0170899867.USD","LU0210533765.USD","LU2168563687.JPY","MVLL","DECP","IE00BJTD4N35.SGD","AVGG","IE00B7KXQ091.USD","LU0889566641.SGD","XDIV","NJUL","LU1732799900.SGD","BK4593","LU0889565833.HKD","LU1551013425.SGD","CORO","CGIC","ELMT","LU2433249047.HKD","GJUL","LU0792757196.USD","LU2264538146.SGD","AVGX","TWSC","LU2242650005.HKD","LU1974910355.USD","LU0965509101.SGD","XYLE","CGGO","LU1670710588.SGD","LU2746668461.USD","BK4527","LU0084288322.USD","LU1119994496.HKD","LU1803068623.USD","LU2461242641.AUD","LU1989772923.USD","LU2756315318.SGD","SHOC","KNOW","SG9999015986.USD","LU0882747503.HKD","ASMU","DOG","LU2592432038.USD","SAVGOmain","THMR","FLTW","LU0096364046.USD","LU0158827948.USD","GSPY","LU1868837722.USD","LU2271345857.HKD","LU0011850046.USD","LU0786609619.USD","SG9999004220.SGD","TSMZ","XNTK","LU0957808578.USD","LU2458330169.SGD","SSS","BK4559","LU0384037296.USD","IE00B5TLWC47.USD","LU1670710661.SGD","LU1923622614.USD","LU0661504455.SGD","LU2756315664.SGD","IE0001KFT4U8.USD","LU0234570918.USD","BK4504","LU1712237335.SGD","LU1934455194.USD","CIBR","MMAX","IE00BHPRN162.USD","UDOW","JANU","LU0823434583.USD","LU2249611893.SGD","LU0689626769.HKD","BK4147","LU1935042991.SGD","IE00BN29S564.USD","LU0572940350.SGD","LU2111349929.HKD","BK4535","GSID","MARW","PMMR","LU0096362180.USD","LU0672654240.SGD","LU2095319765.USD","LU2420271590.USD","FTEC","LU1935042215.USD","LEGR","USPX","HK0000304805.HKD","LU1951200564.SGD","IXN","JUNP","LU2237443895.HKD","LU2360106780.USD","LU0106261372.USD","SPYU","IE00BK4W5M84.HKD","LU0472753341.HKD","LU1979441026.SGD","LU0823421333.USD","IE00BWXC8680.SGD","USXF","ASIA","QDEC","PBFB","IE000BZT7R73.USD","AIFD","LU0251142724.SGD","LU0348723411.USD","TQQQ","ESLG","BK4543",".IXIC","LU1084165304.USD","LU2041044095.USD","LU2506951792.HKD","OEF","CPSD","LU2247934214.USD","TSMY","LU0861579265.USD","IE00BZ9MQY76.HKD","LU0072462343.USD","SG9999015978.USD","YSPY","LU1868838027.USD","ARTY","SPYB","LU2063271972.USD","TOPC","LU2237443622.USD","DMAX","LU0823414551.USD","ONEQ","03165","LU1670756490.USD","LU1868836757.USD","BK4579","SHLD","LU0359201612.USD","SPWO","LU0210528500.USD","LU0310799852.SGD","LU1992135399.USD","CHAT","PMJN","LU2168564149.EUR","LU1037948541.HKD","LU0234572021.USD","LU1989764664.SGD","LU0061474705.USD","SG9999015945.SGD","LU1211504680.USD","LU2357627491.SGD","BK4566","LU2505996681.GBP","SOXY","LU2471134523.USD","LU1815336760.USD","LU0157215616.USD","FB","IE00BVYPNQ40.USD","IE00B1BXHZ80.USD","LU1992135472.HKD","ARMG","LU2750360641.GBP","YMmain","SG9999002224.SGD","AVGU","LU1670711123.USD","INTW","LU1823568750.SGD","LU2430703178.SGD","BK4503","LU2286300806.USD","LU2471134796.USD","LU2430703095.HKD","ESIM","LU2133065610.SGD","DJAN","LU1400636491.USD","IE00B3M56506.USD","LU0985320562.USD","LU1282649067.USD","IE0004445239.USD","LU2361044865.SGD","CPSM","IE00BJLML261.HKD","LU2417539215.USD","GTEK","TQQY","MBCC","AUGZ","IE000M9KFDE8.USD","LU0154236417.USD","LU1732800096.USD","LU1917777945.USD","TDIV","07568","LU0353189680.USD","LU2357125470.USD","LU2237443978.SGD","BK4532","CWI","LU0310800379.SGD","LU1868836591.USD","PQX","DRIV","LU0724617625.USD","LU2242649171.HKD","ARM","LU0080751232.USD","LU2098885051.SGD","ILOW","BK4534","EFA","LU1169590202.USD","ARMA","IE00BBT3K403.USD",".DJI","BK4554","IE00BKVL7J92.USD","IE00BMCWC346.EUR","LU0444973449.USD","LU1267930813.SGD","LU0158827781.USD","AOCT","LU1244550494.USD","SH","SG9999001424.SGD","LU0070217475.USD","SPYH","LU0689472784.USD","EWT","LU0957791311.USD","IE0004445015.USD","INT","MRVU","LU0823414478.USD","LU2089985449.USD","LU2764263039.SGD","LU0323591593.USD","BK4588","LU1202635105.USD","LU2471134952.CNY","03086","LU2168564495.EUR","LU0203347892.USD","LU2148611432.USD","SPDN","LU2108987350.USD","LU1934455277.USD","IE00B775SV38.USD","LU2290526834.HKD","SPXL","03034","IE00BD6J9T35.USD","LU0795875086.SGD","SEPM","LU0345769631.USD","LU1852331112.SGD","LU1064131342.USD","PBJN","LU0143551892.USD","FTXL","IE00BKPKM429.USD","ASMG","BK4604","LU1989772840.SGD","BBUS","LU0878004406.USD","DLNV","IE0009356076.USD","CPSO","LU1868837300.USD","LU2491049909.HKD","IE00BJJMRX11.SGD","LU2360108059.USD","IE00BYQQ9H92.USD","LU0174119429.USD","TTEQ","EDZ","IE0034235188.USD","02834","ESmain","LU2860962120.EUR","IE00BLSP4452.SGD","LU0417517546.SGD","LU2360107168.USD","LU1988902786.USD","DXD","LU0127658192.USD","AUGU","LU2237957902.USD","LU0545039389.USD","BLOX","LU0823434740.USD","APRP","LU0266013472.USD","LU0048584097.USD","HK0000914686.HKD","LU1048588211.SGD","XLK","LU0072462426.USD","LU0143863784.USD","LU0784385840.USD","LU2065171311.SGD","NVDK","LU2125909247.SGD","IE0000B7K699.USD","IE00BQXX3D17.EUR","LU2237443465.HKD","AVGW","LU1934455863.HKD","LU2403377893.USD","PFEB","LU0541502299.USD","IE00BVYPNP33.GBP","IE00BZ199S13.USD","SOXQ","NAPR","BK4602","INTC","LU0321505439.SGD","LU2637965513.SGD","IE00BDGV0183.EUR","BK4575","LU0079474960.USD","TSMG","LU1280957306.USD","LU0210536198.USD","LU1244550221.USD","LU2023250843.SGD","LU1670627923.USD","LU2463028550.USD","03145","SGXZ99366536.SGD","SINTCmain","TINS","PBNV","LU1242518931.SGD","SIXZ","LU0444971666.USD","LU1803068979.SGD","LU1951198990.SGD","LU0225283273.USD","LU1935043023.USD","MESmain","BK4550","SPYI","GPIX","LU0964807845.USD","XTOC","LU2357305700.SGD","LU2065171402.SGD","IE000SO60NU8.SGD","LU1323610961.USD","ARMW","LU2361044949.HKD","LU0069063385.USD","NULC","IE00BMPRXQ63.HKD","VGT","ADVE","LU0572939691.SGD","LU1814569148.SGD","LU0868494708.USD","LU2750360997.AUD","LU0642271901.SGD","LU2213496289.HKD","IE00B19Z9P08.USD","LU1046421795.USD","IE000F7OJYX1.SGD","SOXX","AAUA","INYY","LU0320765059.SGD","JNEU","LU2250418816.HKD","SPY","BK4141","IE00B42XCP33.USD","LU2028103732.USD","LU2361045086.USD","LU0124676726.USD","TRFK","LU1127390331.HKD","LU1935043536.SGD","LU2237438978.USD","IFLR","LU0795875169.SGD","LU1366333091.USD","LU0323239441.USD","LU0511384066.AUD","LU0726765562.USD","LU0878005551.USD","LU0289739343.SGD","LU0553294199.USD","EMC","CHPS","SG9999002232.USD","LU0109391861.USD","LU2720916845.USD","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667914669","title":"諾和諾德公司開啓股份回購計劃。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667914669","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667914669?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 21:14","pubTimestamp":1789391666,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AAPB","AAPW","AAPD","APLY","AAPY","IOSX","AAPU","BGIA","AAPX","AAPE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667663485","title":"諾和諾德(NVO.US)更名「Novo」煥新出發 多線突圍能否驅散股價陰霾？","url":"https://stock-news.laohu8.com/highlight/detail?id=2667663485","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667663485?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 19:44","pubTimestamp":1789386265,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，丹麦药企诺和诺德推出以更短名称“Novo”为核心的全面品牌重塑。诺和诺德已通过下调现金价格、扩大直销以及重新聚焦肥胖症、糖尿病及相关心血管代谢疾病予以回应。与此同时，诺和诺德下一代注射剂CagriSema在近期对比中再次落后于礼来的Zepbound。此外，诺和诺德决定停止两项涉及实验性心血管药物Ziltivekimab的试验，原因是“展示有意义益处的可能性低”。2026年8月27日，中国国家药品监督管理局正式受理诺和诺德口服版Wegovy的上市申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495837.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667266348","title":"諾和諾德(NVO.US)更名「Novo」煥新出發 多線突圍能否驅散股價陰霾？","url":"https://stock-news.laohu8.com/highlight/detail?id=2667266348","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667266348?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 19:44","pubTimestamp":1789386265,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667651989","title":"諾和諾德更名為「諾和（Novo）」，全力爭奪減肥藥市場份額","url":"https://stock-news.laohu8.com/highlight/detail?id=2667651989","media":"环球市场播报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667651989?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 16:52","pubTimestamp":1789375920,"startTime":"0","endTime":"0","summary":"诺和公布了全新经营准则，核心是确立清晰工作重点、简化业务流程，以此实现业务聚焦，提升运转效率。诺和诺德于周一宣布，将对外品牌更名为 “Novo（诺和）” 并更新企业文化，全力争取减肥药领域的市场份额。诺和将于 9 月 21 日资本市场日活动上，详细披露业务战略调整方案。根据礼来财报演示文稿引用的艾昆纬数据，第二季度减肥药市场，诺和市场份额仅 38.8%，落后于礼来的 60.9%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-09-14/doc-inirutnu9457800.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BGIA","APXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667530016","title":"諾和諾德(NVO.US)：公司將品牌名稱更新為「Novo」，並調整企業文化。此舉是為了幫助公司重新奪回減肥藥市場份額。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667530016","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667530016?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 15:15","pubTimestamp":1789370127,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BGIA","APXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667653024","title":"歐洲科技股普遍走低 阿斯麥下跌4.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667653024","media":"东方财富Choice...","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667653024?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 15:10","pubTimestamp":1789369843,"startTime":"0","endTime":"0","summary":"欧洲科技股普遍走低，阿斯麦下跌4.1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609143873376216.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609143873376216.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BGIA","PJIO","PQNT","JIG","SPWO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667653715","title":"阿斯麥歐股跌超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667653715","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667653715?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 15:09","pubTimestamp":1789369795,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IEV","BK4588","VGK","BK4585","VXUS","BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667653219","title":"諾和諾德：「諾和」將作為公司通用名稱；諾和諾德A/S仍為法定名稱。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667653219","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667653219?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 15:05","pubTimestamp":1789369548,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667630538","title":"諾和諾德計劃更名 將去掉 「諾德」 字樣","url":"https://stock-news.laohu8.com/highlight/detail?id=2667630538","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667630538?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 13:25","pubTimestamp":1789363509,"startTime":"0","endTime":"0","summary":"来源：环球市场播报据报道，丹麦制药巨头诺和诺德（Novo Nordisk）将进行品牌重塑，已正式确认将公司名称更改为“Novo”，即去掉“Nordisk（诺德）”字样，并对公司 Logo 和品牌标语进行同步升级。报道表示，相关变更将于本周正式公布，时间在 9 月 21 日资本市场日之前。\n\n美股频道更多独家策划、专家专栏，免费查阅>>\n\n            责任编辑：栎树","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2026/09/14132558426032.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BGIA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":2,"totalSize":139,"code":"91000000","status":"200"}]}}